Stem Cell Banking Market, By Source Type (Umbilical Cord Stem Cell, Adult Stem Cell, Embryonic Stem Cell), By Service Type (Collection and Transportation, Processing, Analysis, Storage), By Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI1354

Pages :148

Formats :

Excel and PDF

Industry : Biotechnology

Market Concentration and Competitive Landscape

Stem Cell Banking Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing Inorganic Growth Activities Such as Agreements among Market Players

Increasing inorganic growth activities such as agreements among market players is expected to drive the market growth. For instance, in February 2021, Cryo-Cell International, Inc., a private cord blood bank that separates and stores stem cells, entered into a collaborative license agreement with Duke University, North Carolina, U.S. The agreement grants Cryo-Cell the rights to proprietary processes and regulatory data related to cord blood and cord tissue developed at Duke University. Cryo-Cell plans to explore, test, and administer and these therapies are offered to people with diseases such cerebral palsy, autism, multiple sclerosis, and COVID-19 for which there are not many U.S. FDA-approved medicines. These treatments utilize the unique immunomodulatory and potential regenerative properties derived from cord blood and cord tissue.

Key Players Insights